White blood cell counts or leukocytes could be a crucial indicator of COVID-19 severity in women, impacting treatment strategies, stated new research.

Higher levels of leukocytes -- a form of white blood cell -- are associated with more severe symptoms of long COVID among older women, researchers reported.

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

The study, led by researchers from Rush University, Harvard Medical School, and Ohio State University, aims to better understand pre-existing risk factors

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people. A new study, however, suggests that it may now be easier to predict who is most likely to suffer with more serious disease symptoms based on leukocyte (white blood cell) count.

A new study based on Women’s Health Initiative data suggests that a readily available and inexpensive clinical marker of inflammation could be key in predicting debilitating COVID outcomes in postmenopausal women.

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most